Aqualyx vs Kybella: Comparing Deoxycholic Acid Lipolysis Products

Injectable lipolysis has become an established option for stubborn, diet-resistant fat pockets, and two products dominate discussion of it: Aqualyx and Kybella. Both rely on the same underlying chemistry but differ in formulation history, regulatory status and packaging. Comparing them on technical merits rather than brand reputation alone is a more useful basis for stocking and positioning decisions.

The Shared Mechanism: Deoxycholic Acid and Lipolysis

Both products work through deoxycholate chemistry, which disrupts the membrane of fat cells and releases stored lipids for clearance through the lymphatic system over the following weeks. This general process is referred to as injection lipolysis, and it underpins both formulations despite their different regulatory paths. Results are not immediate — visible changes in the treated area typically develop over several weeks as the body clears the released lipid content, and most patients require more than one session to reach their desired outcome, regardless of which product is used.

Patient Candidacy Considerations

Injectable lipolysis is generally positioned for well-defined, diet-resistant pockets of subcutaneous fat rather than as a substitute for weight management or a treatment for larger-volume fat deposits. Patients with realistic expectations about the localised, gradual nature of the result, and who understand that several sessions are typically required, tend to report the highest satisfaction with either product. Screening for suitability, including reviewing relevant medical history, remains part of the assessment regardless of which formulation a clinic offers.

What Distinguishes Aqualyx

Aqualyx is manufactured by an Italian biomedical company and is described as a compounded solution from the deoxycholate family. It is used across a broad range of treatment areas, including the thighs, knees, abdomen, buttocks, back, arms and submental region, and carries CE marking with wide use internationally.

What Distinguishes Kybella

Kybella, manufactured in the United States, is a single-molecule deoxycholic acid formulation. Its approved indication is narrower — it holds regulatory approval specifically for submental fat, commonly known as a double chin — though some practitioners use it off-label in other areas within the bounds of their local regulatory framework.

Regulatory Status and Market Availability

The clearest distinction between the two products is regulatory scope rather than efficacy. Kybella holds a specific approval for one indication in markets where it is authorised; Aqualyx has broader international use and CE marking but does not carry that same approval pathway. This affects which claims a clinic can make, what documentation is required, and which product is appropriate depending on jurisdiction.

Practical Considerations for Clinics

Vial concentration and format differ between the two products, which affects how many units are needed to treat a given area and should factor into stocking decisions rather than a simple per-vial price comparison. Beyond product choice, the same clinical fundamentals apply regardless of which is selected: careful patient selection, awareness of contraindications such as pregnancy or certain coagulation and metabolic conditions, and setting realistic expectations that lipolysis is typically a multi-session process rather than a single-treatment fix. Sessions for both products are typically spaced several weeks apart to allow the inflammatory response from one treatment to resolve before the next, which also affects how quickly a course of treatment can be completed.

The Takeaway

Aqualyx and Kybella target the same problem through the same deoxycholate mechanism. The meaningful differences lie in regulatory approval scope and treatment-area versatility rather than in underlying efficacy, and the right choice for a given clinic depends on the regulatory framework in play and the treatment areas patients most often request.

To review injectable lipolysis products, browse the body contouring catalogue, including Aqualyx and Kybella.